Clinical trial
A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in…
NCT00401076 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00401076 |
|---|---|
| Title | A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency |
| Official title | A One-year Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy |
| Intervention type | Drug |
| Interventions | SA-001 |
| Enrollment | 80 |
| Start date | Jul 1, 2008 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Nov 17, 2006 |
| Last update posted | Aug 1, 2011 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: